Related Experiment Video

Updated: May 10, 2025

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

3.4K

Modulating the JAK/STAT pathway with natural products: potential and challenges in cancer therapy

Bhagyalakshmi Nair1,2, Anjana Menon1,3, M Rithwik Kalidas1,3

  • 1Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Ponekkara, P.O., Kochi, Kerala, 682041, India.

Discover Oncology
|April 23, 2025
PubMed

Insights

Natural compounds like Curcumin can target the Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) pathway, offering potential in cancer therapy by inhibiting key signaling steps. Further research and improved delivery methods are needed to overcome bioavailability challenges.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Oncology

Background:

  • The Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) pathway is crucial for cellular functions and its dysregulation is linked to cancer.
  • Natural products are increasingly investigated for their therapeutic potential in various diseases.

Purpose of the Study:

  • To review the therapeutic potential of natural products as modulators of the JAK/STAT pathway in cancer.
  • To evaluate the mechanisms by which phytochemicals like Curcumin, Resveratrol, Apigenin, and EGCG impact JAK/STAT signaling.
  • To assess the promise and challenges of using these compounds as complementary cancer therapies.

Main Methods:

  • Systematic evaluation of peer-reviewed studies.
  • Analysis of phytochemical mechanisms targeting JAK/STAT phosphorylation, dimerization, and DNA binding.
  • Review of evidence for anticancer activity.

Main Results:

  • Phytochemicals including Curcumin, Resveratrol, Apigenin, and EGCG inhibit JAK/STAT pathway components.
  • These natural compounds demonstrate anticancer effects by interfering with critical signaling steps.
  • Evidence suggests potential as complementary agents alongside conventional treatments.

Conclusions:

  • Natural products show promise in modulating the JAK/STAT pathway for cancer treatment.
  • Challenges such as poor bioavailability and limited clinical validation require further investigation.
  • Advanced drug delivery systems and rigorous clinical trials are necessary to realize their full therapeutic potential.
Keywords:
Anticancer mechanismsCancer therapyJAK/STAT pathwayMolecular targeted therapyNatural productsPhytochemicals

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.6K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.4K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
105.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.6K